FindTrial
Sign In

The efficacy of low dose oral corticosteroids for patients with White Dots Syndrome

The efficacy of low dose oral corticosteroids for patients with White Dots Syndrome

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800017294
Enrollment
Unknown
Registered
2018-07-23
Start date
2018-08-01
Completion date
Unknown
Last updated
2018-07-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

white dots syndrome

Interventions

intervation group:oral corticosteroids
control group:obervation
MEWDS intervation group:oral corticosteriods
MEWDS control group:observation

Sponsors

ZhongShan Ophthalimic Center
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. Diagnosed with active WDS; 2. Aged 18 to 60 year old; 3. BCVA must be = 19 in the study eye; 4. Be willing to participate the trial and be followed up at least 6 month.

Exclusion criteria

Exclusion criteria: contraindication to oral corticosteroids; with other eye disease; with active CNV and need to be treated immediately; Women of child-bearing potential;History of systematical drugs treatment with 6 months .

Design outcomes

Primary

MeasureTime frame
active course time;—

Secondary

MeasureTime frame
BCVA;complications;—

Countries

China

Contacts

Public ContactZhang Xiongze

ZhongShan Ophthalimic Center

zhangxiongze@foxmail.com+86 87330394

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026